title: [Behavior of plasma pancreatic polypeptides and motilin in obese patients subjected to biliopancreatic bypass].
abstract: Biliopancreatic bypass for obesity entails a 2/3 distal gastrectomy with Roux-en-y reconstruction, being the small bowel transected at its midpoint and the enteroenteroanastomosis placed 50 cm proximal to the ileocecal value. Pancreatic polypeptide (PP) and motilin fasting and meal-stimulated plasma concentrations were determined in 13 nonobese healthy volunteers, in 13 nonoperated obese patients, in 9 subjects within two months, in 12 subjects four to twelve months, and in 7 subjects fifteen to twenty months after operation. There were no significant differences in PP fasting levels between either the obese and control groups or between the postoperative groups and the preoperative group. Both meal-stimulated peak and integrated response values were similar in the obese and control groups, and were strikingly and progressively reduced postoperatively, with statistically significant difference between all postoperative groups and preoperative group. Mean plasma motilin fasting and peak values were higher in the obese group than in the control group, and significantly reduced in the 4-12 and 15-20 month group. Despite the huge variability among data, the integrated response in the 0-2 month group was significantly decreased in comparison with the preoperative group, while a subsequent progressive increase was shown by the 4-12 and 15-20 month groups.
mesh_terms: D005215:Fasting; D005500:Follow-Up Studies; D005768:Gastrointestinal Hormones / Q000097:blood*; D006801:Humans; D007082:Ileum / Q000601:surgery*; D009037:Motilin / Q000097:blood*; D009765:Obesity / Q000097:blood / Q000628:therapy*; D010191:Pancreatic Polypeptide / Q000097:blood*; D013270:Stomach / Q000601:surgery*; D013997:Time Factors
chemical_list: D005768:Gastrointestinal Hormones; D009037:Motilin; D010191:Pancreatic Polypeptide
vernacular_title: Comportamento del polipeptide pancreatico e della motilina plasmatici in soggetti obesi sottoposti a bypass biliopancreatico.